Procaps SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Procaps SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10937
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:コロンビア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Procaps SAS (Procaps) is a manufacturing and commercializing company that provides pharmaceutical forms. The company provides softigel products such as RX products, OTC products, natural products, omega 3 fish oils, gummies and veterinary products, among others. Its hospitalaria unit offers bioser, biotec, farmionni and vademecum products. Procaps provides services such as packing design, training for product managers and sales teams, marketing outline for medical sales representatives and dossiers for stability reports and product samples. The company caters to pharmaceutical, cosmetic, nutritional supplement industries, and others. It operates through its business units. Procaps is headquartered in Barranquilla, Colombia.

Procaps SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Procaps SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Procaps SAS, Medical Devices Deals, 2012 to YTD 2018 9
Procaps SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Procaps SAS, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
International Finance to Invest in Procaps 11
Partnerships 12
Ani Pharma Enters Into Co-Development Agreement With Sofgen Pharma For Oral Soft Gel Prescription Product 12
Licensing Agreements 13
OncBioMune Enters into Licensing Agreement with PROCAPS 13
Ani Pharma Enters Into Licensing Agreement With Sofgen Pharma For Oral Soft Gel Product 14
Procaps SAS – Key Competitors 15
Procaps SAS – Key Employees 16
Procaps SAS – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Affiliate 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Procaps SAS, Pharmaceuticals & Healthcare, Key Facts 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Procaps SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Procaps SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Procaps SAS, Medical Devices Deals, 2012 to YTD 2018 9
Procaps SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
International Finance to Invest in Procaps 11
Ani Pharma Enters Into Co-Development Agreement With Sofgen Pharma For Oral Soft Gel Prescription Product 12
OncBioMune Enters into Licensing Agreement with PROCAPS 13
Ani Pharma Enters Into Licensing Agreement With Sofgen Pharma For Oral Soft Gel Product 14
Procaps SAS, Key Competitors 15
Procaps SAS, Key Employees 16
Procaps SAS, Other Locations 17
Procaps SAS, Subsidiaries 17
Procaps SAS, Affiliate 18

List of Figures
Procaps SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Procaps SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Procaps SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Procaps SAS, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Procaps SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MaaT Pharma-製薬・医療分野:企業M&A・提携分析
    Summary MaaT Pharma (MaaT) is a biotechchnology company that develop novel treatments for Gut Microbiota - dysbiosis related diseases. The company is working on two projects, which are in the developmental stage, namely, MaaT001, an innovative live frozen inoculum suspension and MaaT002, an innovati …
  • Getlink SE:企業の戦略・SWOT・財務分析
    Getlink SE - Strategy, SWOT and Corporate Finance Report Summary Getlink SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Sequa Petroleum NV (MLSEQ):企業の財務・戦略的SWOT分析
    Summary Sequa Petroleum NV (Sequa Petroleum) is an oil and gas company. It develops, acquires, monetises, produces and finances oil and natural gas assets. The company holds assets in Europe, Central and West Africa and the Middle East. Sequa Petroleum has a large development and producing area in N …
  • Sprott Resource Holdings Inc. (SRHI):企業の財務・戦略的SWOT分析
    Sprott Resource Holdings Inc. (SRHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務情報
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Cott Corporation:企業の戦略・SWOT・財務情報
    Cott Corporation - Strategy, SWOT and Corporate Finance Report Summary Cott Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Xcel Energy Inc (XEL):電力:M&Aディール及び事業提携情報
    Summary Xcel Energy Inc. (Xcel Energy) is a vertically-integrated energy utility that generates, procures, transmits, distributes and sells electricity; and transports, stores and distributes natural gas through its subsidiaries. The company owns and operates generation assets utilizing diverse fuel …
  • Faxitron Bioptics LLC:医療機器:M&Aディール及び事業提携情報
    Summary Faxitron Bioptics LLC (Faxitron) is a medical device company that develops cabinet x-ray systems for specimen radiography, research and NDT applications. The company offers clinical products and lifescience products. Its clinical products include pathvision, corevision, biovision, localizer, …
  • BNK Petroleum Inc (BKX):石油・ガス:M&Aディール及び事業提携情報
    Summary BNK Petroleum Inc (BNK Petroleum) is an oil and gas company. The company explores, produces and acquires large hydrocarbon reserves. The company’s project includes Tishomingo Field, Gapowo B-1 well and other operations in Spain. Its Tishomingo Field is located in Ardmore Basin in Oklahoma, t …
  • Companhia Energetica de Minas Gerais – CEMIG:企業のM&A・事業提携・投資動向
    Companhia Energetica de Minas Gerais - CEMIG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Companhia Energetica de Minas Gerais - CEMIG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Tadano Ltd:企業の戦略・SWOT・財務情報
    Tadano Ltd - Strategy, SWOT and Corporate Finance Report Summary Tadano Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Lennar Corporation:企業のM&A・事業提携・投資動向
    Lennar Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lennar Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Berkley Renewables Inc (BKS):企業の財務・戦略的SWOT分析
    Berkley Renewables Inc (BKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Hargreaves Services Plc:企業の戦略・SWOT・財務分析
    Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report Summary Hargreaves Services Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Medline Industries Inc:医療機器:M&Aディール及び事業提携情報
    Summary Medline Industries Inc (Medline) is a manufacturer and distributor of healthcare supplies in the US. The company offers products under various categories, including Exam Gloves, Textiles, Durable Medical Equipment, Skin Care, OR Kits, Protective Apparel, Gauze, Packs and Gowns, Bathing Syste …
  • IBC Solar AG:企業の戦略的SWOT分析
    IBC Solar AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Samba Private Banking:企業の戦略・SWOT・財務分析
    Samba Private Banking - Strategy, SWOT and Corporate Finance Report Summary Samba Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999):企業の財務・戦略的SWOT分析
    China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the …
  • Mycenax Biotech Inc (4726):製薬・医療:M&Aディール及び事業提携情報
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆